Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KUBOTEK, The Current Fiscal Year's Net Income to Widen
7709 KUBOTEK CORPORATION 【J-GAAP】
Earnings ReportKUBOTEK CORPORATION <7709> [TSE Std] announced its financial results after the market closed on May 15th (15:40). The consolidated net loss for the fiscal year ending March 2025 was loss of 200 million yen, a reduction in the deficit compared to loss of 200 million yen in the previous term. For the fiscal year ending March 2026, the consolidated net loss is expected to be loss of 210 million yen. This will mark the seventh consecutive term of losses.
In the most recent three-month period, from January to March (4Q), the consolidated net loss expanded to a loss of 250 million yen (compared to a loss of 32 million yen in the same period last year). The operating profit/loss margin drastically worsened from 2.4% in the same period last year to -75.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 1,217 | -194 | -179 | -204 | -14.9 | 0 | May 15, 2023 | J-GAAP |
Mar, 2024 | 1,306 | -216 | -219 | -273 | -19.8 | 0 | May 15, 2024 | J-GAAP |
Mar, 2025 | 1,662 | -125 | -126 | -200 | -14.6 | 0 | May 15, 2025 | J-GAAP |
YoY | +27.3% | +42.1% | +42.5% | +26.7% | +26.5% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Guidance | 1,662 | -125 | -127 | -201 | -14.6 | 0 | Apr 24, 2025 | J-GAAP |
Mar, 2025 Results | 1,662 | -125 | -126 | -200 | -14.6 | 0 | May 15, 2025 | J-GAAP |
Revision Rate | 0.0% | 0.0% | +0.8% | +0.5% | +0.1% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 | 1,213 | 158 | 159 | 155 | 11.3 | 0 | Nov 1, 2024 | J-GAAP |
Apr - Sep, 2025 Guidance | 1,200 | 75 | 70 | 65 | 4.7 | 0 | May 15, 2025 | J-GAAP |
YoY | -1.1% | -52.5% | -56.0% | -58.1% | -58.3% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2024 | 1,306 | -216 | -219 | -273 | -19.8 | 0 | May 15, 2024 | J-GAAP |
Mar, 2025 | 1,662 | -125 | -126 | -200 | -14.6 | 0 | May 15, 2025 | J-GAAP |
Mar, 2026 Guidance | 1,750 | -170 | -180 | -210 | -15.3 | 0 | May 15, 2025 | J-GAAP |
YoY | +5.3% | -36.0% | -42.9% | -5.0% | -4.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 660 | 16 | 16 | -32 | -2.3 | 2.4 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 535 | 37 | 35 | 34 | 2.5 | 6.9 | Aug 2, 2024 | J-GAAP |
Jul - Sep, 2024 | 678 | 121 | 124 | 121 | 8.8 | 17.8 | Nov 1, 2024 | J-GAAP |
Oct - Dec, 2024 | 208 | -101 | -105 | -105 | -7.7 | -48.6 | Jan 31, 2025 | J-GAAP |
Jan - Mar, 2025 | 241 | -182 | -180 | -250 | -18.2 | -75.5 | May 15, 2025 | J-GAAP |
YoY | -63.5% | - | - | -681.3% | -682.8% |
Related Articles
RESORTTRUST, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend
PhoenixBio, Returning to Profitability This Year
KURAMOTO, Jan-Mar (1Q) Net Income Turns to Loss
KUZE, 11% Decrease in Ordinary Profit for The Current Fiscal Year
ICDA Holdings, 4% Increase in Ordinary Profit, Update Record High for Third Consecutive Term
LUCKLAND, Jan-Mar (1Q) Ordinary Profit Increases by 2.2 times
Delta-Fly Pharma, The Current Fiscal Year's Net Income to Narrow
AIMECHATEC, Jul-Mar (Cumulative 3Q) Ordinary Profit Turns to Profit, Jan-Mar Ordinary Profit Loss Narrows
MAEDA KOSEN, Jul-Mar (Cumulative 3Q) Ordinary Profit Increases by 25%, Jan-Mar Ordinary Profit Increases by 11%
KLASS, The Current Fiscal Year Ordinary Profit Revised Upward by 19%